Emerging role of LINC00461 in cancer

被引:18
作者
Zhang, Qiudan [1 ,2 ]
Zhong, Chenming [2 ]
Shen, Jinze [1 ]
Chen, Sang [2 ]
Jia, Yunhua [1 ]
Duan, Shiwei [1 ]
机构
[1] Zhejiang Univ City Coll, Sch Med, Dept Clin Med, Hangzhou 310015, Zhejiang, Peoples R China
[2] Ningbo Univ, Med Genet Ctr, Sch Med, Ningbo 315211, Zhejiang, Peoples R China
关键词
LINC00461; Cancer; Competing endogenous RNA; Diagnosis; Prognosis; Drug resistance; LONG NONCODING RNA; NF-KAPPA-B; CELL-PROLIFERATION; BREAST-CANCER; MIGRATION; INVASION; SUPPRESSES; NETWORK; INHIBITION; PATHWAY;
D O I
10.1016/j.biopha.2022.113239
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
LINC00461 is located in the intergenic region between the protein-coding genes MEF2C and TMEM161B. LINC00461 upregulation was associated with the risk of 13 tumors and was strongly associated with clinicopathologic features and poor prognosis in 11 tumors. LINC00461 is involved in resistance to four anticancer drugs, including sunitinib for renal cell carcinoma, cisplatin for head and neck squamous cell carcinoma and rectal cancer, temozolomide for glioma, and docetaxel for breast cancer. LINC00461 can sponge 18 miRNAs to form a complex ceRNA network that regulates the expression of a large number of downstream genes. LINC00461 is involved in the MAPK/ERK signaling pathway and PI3K/AKT signaling pathway, thereby promoting tumorigenesis. Notably, knockdown of LINC00461 in exosomes antagonizes tumor cell proliferation in multiple myeloma. This article summarizes the diagnostic, prognostic, and therapeutic value of LINC00461 in various tumors, and systematically describes the ceRNA network and signaling pathways associated with LINC00461, providing potential directions for future LINC00461 research.
引用
收藏
页数:9
相关论文
共 64 条
[1]   PHLPP2 suppresses the NF-κB pathway by inactivating IKKβ kinase [J].
Agarwal, Nitin Kumar ;
Zhu, Xiaoping ;
Gagea, Mihai ;
White, Charles L., III ;
Cote, Gilbert ;
Georgescu, Maria-Magdalena .
ONCOTARGET, 2014, 5 (03) :815-823
[2]  
ARAKAWA T, 1986, J BIOL CHEM, V261, P8534
[3]   New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities [J].
Ashrafizadeh, Milad ;
Mirzaei, Sepideh ;
Hashemi, Farid ;
Zarrabi, Ali ;
Zabolian, Amirhossein ;
Saleki, Hossein ;
Sharifzadeh, Seyed Omid ;
Soleymani, Leyla ;
Daneshi, Salman ;
Hushmandi, Kiavash ;
Khan, Haroon ;
Kumar, Alan Prem ;
Aref, Amir Reza ;
Samarghandian, Saeed .
BIOMEDICINE & PHARMACOTHERAPY, 2021, 141
[4]   Regulation and Function of AQP4 in the Central Nervous System [J].
Assentoft, Mette ;
Larsen, Brian Roland ;
MacAulay, Nanna .
NEUROCHEMICAL RESEARCH, 2015, 40 (12) :2615-2627
[5]   microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer [J].
Braconi, C. ;
Kogure, T. ;
Valeri, N. ;
Huang, N. ;
Nuovo, G. ;
Costinean, S. ;
Negrini, M. ;
Miotto, E. ;
Croce, C. M. ;
Patel, T. .
ONCOGENE, 2011, 30 (47) :4750-4756
[6]   Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression [J].
Chang, SH ;
Liu, CH ;
Conway, R ;
Han, DK ;
Nithipatikom, K ;
Trifan, OC ;
Lane, TF ;
Hla, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (02) :591-596
[7]   LINC00461 affects the survival of patients with renal cell carcinoma by acting as a competing endogenous RNA for microRNA-942 [J].
Chen, Yicheng ;
He, Jinkui ;
Su, Changju ;
Wang, Huan ;
Chen, Yuanlei ;
Guo, Wenhao ;
Li, Yining ;
Ding, Guoqing .
ONCOLOGY REPORTS, 2019, 42 (05) :1924-1934
[8]   Cisplatin in cancer therapy: Molecular mechanisms of action [J].
Dasari, Shaloam ;
Tchounwou, Paul Bernard .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 740 :364-378
[9]   Sunitinib [J].
Deeks, Emma D. ;
Keating, Gillian M. .
DRUGS, 2006, 66 (17) :2255-2266
[10]   Oncogenic effects of evolutionarily conserved noncoding RNA ECONEXIN on gliomagenesis [J].
Deguchi, S. ;
Katsushima, K. ;
Hatanaka, A. ;
Shinjo, K. ;
Ohka, F. ;
Wakabayashi, T. ;
Zong, H. ;
Natsume, A. ;
Kondo, Y. .
ONCOGENE, 2017, 36 (32) :4629-4640